Socioeconomic Burden of Pyogenic Liver Abscess Caused by Klebsiella Pneumoniae from a Teaching Hospital in East China
DOI: https://doi.org/10.2147/idr.s447506
2024-04-24
Infection and Drug Resistance
Abstract:Zhenzhu Wu, 1 Jie Li, 1 Peipei Fang, 1 Chenwei Pan, 1 Yi Chen 2 1 Department of Infectious Disease, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, 325000, People's Republic of China; 2 Department of Gastroenterology, Wenzhou People's Hospital, Wenzhou, Zhejiang, 325000, People's Republic of China Correspondence: Yi Chen; Zhenzhu Wu, Email ; Background: The prevalence of pyogenic liver abscess (PLA) is increasing worldwide. However, evaluation on its economic burden is still lack. Methods: A retrospective study that included all patients identified PLA from 2017 to 2020 was conducted. Clinical information and hospital costs were collected through the electronic medical records. We evaluated the economic burden using disability-adjusted life years (DALYs). Differences in socioeconomic burdens between Klebsiella pneumoniae -caused liver abscesses (KPLA) and non- Klebsiella pneumoniae -caused liver abscesses (non-KPLA) were compared. Results: We found 327 patients identified PLA in the study, including 146 with KPLA and 181 with non-KPLA. The demographic characteristics, median hospital stay, severity, and in-hospital mortality were similar between the two groups. The median total in-hospital cost was higher in the non-KPLA than in the KPLA group, although no statistical difference was found (&dollar3607.2 vs &dollar3424.6; P = 0.446). The median DALY loss was significantly higher in the KPLA than in the non-KPLA group [1.49 (0.97– 2.30) vs 1.27 (0.87– 1.89); P = 0.033)], and male patients presented a higher average DALY loss than female patients. KPLA had a substantially greater median indirect economic loss than the non-KPLA group [&dollar1442.8 (915.9– 17,221.5) vs &dollar1232.5 (764.6– 15,473.0); P = 0.028], and indirect economic loss exhibited a significant increase from 2017 to 2020 in patients with PLA. No differences were found in the socioeconomic burden between the two groups [&dollar8019.6 (4200.3– 21,832.1) vs &dollar7436.4 (4023.2– 19,063.9); P = 0.172]. Conclusion: The economic burden of PLA is significant, particularly in patients with KP. Patients with KPLA experienced increased DALY loss and indirect economic loss than non-KPLA. PLA must be prioritized as the indirect economic burden rises annually. Keywords: pyogenic liver abscess, Klebsiella pneumoniae , socioeconomic burden, disability-adjusted life years Pyogenic liver abscess (PLA) is an intrahepatic purulent infection caused by various microorganisms. With the rise of diabetic patients, abdominal invasive surgeries for hepatobiliary diseases, longer life expectancies, and widespread use of immunosuppressive drugs in organ transplants and malignancy patients, the incidence of PLA has increased globally with regional variations. 1–3 According to previous studies, the incidence of PLA increased from 11 to 15 cases per 100,000 population between 2000 and 2011 in Taiwan. 2 The crude annual incidence in China mainland increased from 0.9 to 5.3 cases per 100,000 population between 2000 and 2011. 1,3,4 Therefore, the social and economic burden cannot be overlooked. DALY is a metric widely used for evaluating disease burden. It was first proposed in the Global Burden of Disease (GBD) study 5 and has been widely used since then. 5–8 It is the summation of the lives lost due to death and the time lived in disabled states due to the disease. 9 Previous articles on PLA have focused on clinical and microbiological aspects 10–14 and ignored the socioeconomic burden of PLA, specifically KP-related PLA. Liu et al 15 explored the economic burden of PLA but only focused on the direct hospitalization costs. No reports have explained the indirect socioeconomic costs of PLA yet. In this study, we retrospectively evaluated the direct hospitalization costs, indirect socioeconomic burden, and disability-adjusted life years (DALYs) in patients with PLA and their dynamic changes in recent years. This may improve our understanding of the socioeconomic status of patients with PLA and enhance infection prevention strategies. Although the problem of KPLA has raised widespread concern, little is known about the influence of KP on economic burden. Therefore, we aimed to clarify the potential clinical and economic cost of KPLA. A retrospective cohort study of adult inpatients with PLA at the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University (Wenzhou, China) was conducted from January 1, 2017, to December 31, 2020. The inclusion criteria were as follows: (1) clinical manifestations o -Abstract Truncated-
pharmacology & pharmacy,infectious diseases